生物电子医药市场－全球产业规模、份额、趋势、机会和预测（按类型、产品、应用、最终用户、地区和竞争细分，2020-2030 年）

2024 年全球生物电子医疗市场价值为 235.4 亿美元，预计到 2030 年将达到 335.9 亿美元，预测期内的复合年增长率为 6.10%。市场成长的动力来自于心血管和神经系统疾病等慢性疾病的先进医疗解决方案日益增长的需求。政府对生物电子疗法开发的支持和投资不断增加，正在推动全球生物电子疗法的采用。此外，随着科技在医疗保健领域的进一步融合，起搏器和除颤器等设备的使用正变得越来越普遍。人们越来越意识到这些设备的好处，例如减少副作用和改善患者治疗效果，这进一步加速了需求。这些因素，再加上可支配收入的增加和人口老化加剧，预计将维持全球生物电子医疗市场的上升趋势。

关键市场驱动因素

慢性病盛行率上升和人口老化

主要市场挑战

高成本和有限的报销政策

主要市场趋势

与数位健康和​​人工智慧的融合

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：临床试验分析

第六章：全球生物电子医学市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（植入式、非侵入式）
  • 依产品（植入式心臟復律去颤器、心臟节律器、人工耳蜗、脊髓刺激器、深部脑部刺激器、经皮电神经刺激器、荐神经刺激器、迷走神经刺激器、其他）
  • 依应用（心律不整、疼痛管理、感音神经性听损、巴金森氏症、震颤、忧郁症、难治性忧郁症、癫痫、尿失禁和大便失禁、其他）
  • 按最终使用者（医院、个人使用者、家庭护理中心、门诊手术中心、专科诊所、其他）
  • 按地区（北美、欧洲、亚太、南美、中东和非洲）
  • 按公司分类（2024）
• 市场地图
  • 按产品
  • 按应用
  • 依技术
  • 按来源
  • 按地区

第七章：北美生物电子医疗市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第八章：欧洲生物电子医学市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第九章：亚太生物电子医药市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第十章：南美洲生物电子医学市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 11 章：中东和非洲生物电子医学市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 12 章：市场动态

• 驱动程式
• 挑战

第十三章：市场趋势与发展

• 最新动态
• 併购
• 产品发布

第 14 章：全球生物电子医疗市场：SWOT 分析

第 15 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 16 章：竞争格局

• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• Cochlear Ltd.
• LivaNova PLC
• Soterix Medical Inc.
• Bioinduction Ltd.
• GiMer Medical
• CEFALY
• BioControl Medical

第 17 章：策略建议

第18章调查会社について・免责事项

The Global Bioelectronic Medicine Market was valued at USD 23.54 billion in 2024 and is projected to reach USD 33.59 billion by 2030, growing at a CAGR of 6.10% during the forecast period. Market growth is being driven by rising demand for advanced healthcare solutions for chronic illnesses such as cardiovascular and neurological disorders. Increasing governmental support and investments in the development of bioelectronic therapies are boosting global adoption. Additionally, with greater integration of technology in healthcare, the use of devices like pacemakers and defibrillators is becoming more widespread. The growing awareness of the benefits associated with these devices-such as reduced side effects and improved patient outcomes-further accelerates demand. These factors, coupled with rising disposable incomes and a growing aging population, are expected to sustain the upward trajectory of the bioelectronic medicine market globally.

Key Market Drivers

Rising Prevalence of Chronic Diseases and Aging Population

The increasing global burden of chronic diseases-such as cardiovascular ailments, diabetes, and neurological disorders-is significantly contributing to the expansion of the bioelectronic medicine market. These long-term conditions often require continuous and targeted treatment approaches. Bioelectronic medicine, which includes technologies like pacemakers and neurostimulators, offers precise and less invasive alternatives to conventional pharmaceuticals. According to WHO, cardiovascular diseases account for nearly 17.9 million deaths annually, making them the leading cause of mortality worldwide. Similarly, the International Diabetes Federation estimated that 537 million adults lived with diabetes in 2021-a figure projected to grow to 643 million by 2030. This trend is further compounded by global demographic shifts, with one in six individuals expected to be over 65 by 2050. These factors collectively emphasize the need for reliable and innovative bioelectronic interventions, especially among elderly populations who are more vulnerable to chronic illnesses and adverse drug reactions.

Key Market Challenges

High Costs and Limited Reimbursement Policies

Despite its therapeutic potential, the bioelectronic medicine market faces challenges related to the high cost of devices and limited reimbursement coverage. Advanced implantable devices such as neurostimulators and defibrillators involve complex manufacturing processes and high R&D investments, resulting in substantial costs. In low- and middle-income countries, these high prices often place such treatments out of reach for a significant portion of the population. Furthermore, reimbursement frameworks for bioelectronic therapies are inconsistent across regions. In many cases, insurance does not fully cover the cost of treatment, making it financially burdensome for patients. WHO data shows that out-of-pocket medical expenses push approximately 100 million people into extreme poverty every year. These economic constraints hinder wider adoption and market penetration of bioelectronic medical solutions, especially in developing healthcare systems.

Key Market Trends

Integration with Digital Health and Artificial Intelligence

A major trend shaping the bioelectronic medicine market is the integration of digital health technologies and artificial intelligence (AI). AI is enhancing the precision and effectiveness of bioelectronic therapies by enabling real-time analysis of patient data and supporting personalized treatment protocols. Wearable bioelectronic devices are increasingly being used for continuous health monitoring, allowing for early intervention and proactive care. Government bodies are actively promoting these digital advancements. For example, the U.S. Department of Health and Human Services supports the adoption of AI in healthcare to improve efficiency and patient outcomes. Similarly, the European Commission's strategy for digital health encourages the implementation of smart medical technologies. The convergence of AI, data analytics, and bioelectronic medicine is paving the way for next-generation diagnostics and therapeutics, while also facilitating remote care and expanding access to treatment.

Key Market Players

• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• Cochlear Ltd.
• LivaNova PLC
• Soterix Medical Inc.
• Bioinduction Ltd.
• GiMer Medical
• CEFALY
• BioControl Medical

Report Scope:

In this report, the Global Bioelectronic Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bioelectronic Medicine Market, By Type:

• Implantable
• Non-invasive

Bioelectronic Medicine Market, By Product:

• Implantable cardioverter defibrillators
• Cardiac pacemakers
• Cochlear implants
• Spinal cord stimulators
• Deep brain stimulators
• Transcutaneous electrical nerve stimulators
• Sacral nerve stimulators
• Vagus nerve stimulators
• Others

Bioelectronic Medicine Market, By Application:

• Arrhythmia
• Pain management
• Sensorineural hearing loss
• Parkinson's disease
• Tremor
• Depression
• Treatment-resistant depression
• Epilepsy
• Urinary and fecal incontinence
• Others

Bioelectronic Medicine Market, By End User:

• Hospitals
• Individual Users
• Homecare Centers
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Bioelectronic Medicine Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bioelectronic Medicine Market.

Available Customizations:

Global Bioelectronic Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

• 5.1. Ongoing Clinical Trials
• 5.2. Completed Clinical Trials
• 5.3. Terminated Clinical Trials
• 5.4. Breakdown of Pipeline, By Development Phase
• 5.5. Breakdown of Pipeline, By Status
• 5.6. Breakdown of Pipeline, By Study Type
• 5.7. Breakdown of Pipeline, By Region
• 5.8. Clinical Trials Heat Map

6. Global Bioelectronic Medicine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Implantable, Non-invasive)
  • 6.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
  • 6.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
  • 6.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
  • 6.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 6.2.6. By Company (2024)
• 6.3. Market Map
  • 6.3.1. By Product
  • 6.3.2. By Application
  • 6.3.3. By Technique
  • 6.3.4. By Source
  • 6.3.5. By Region

7. North America Bioelectronic Medicine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Implantable, Non-invasive)
  • 7.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
  • 7.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
  • 7.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
  • 7.2.5. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Bioelectronic Medicine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Canada Bioelectronic Medicine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. Mexico Bioelectronic Medicine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User

8. Europe Bioelectronic Medicine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Implantable v/s Non-invasive)
  • 8.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
  • 8.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
  • 8.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
  • 8.2.5. By Country
• 8.3. Europe: Country Analysis
  • 8.3.1. France Bioelectronic Medicine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. Germany Bioelectronic Medicine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. United Kingdom Bioelectronic Medicine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. Italy Bioelectronic Medicine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Spain Bioelectronic Medicine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Asia-Pacific Bioelectronic Medicine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Implantable v/s Non-invasive)
  • 9.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
  • 9.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
  • 9.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
  • 9.2.5. By Country
• 9.3. Asia-Pacific: Country Analysis
  • 9.3.1. China Bioelectronic Medicine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. India Bioelectronic Medicine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Japan Bioelectronic Medicine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User
  • 9.3.4. South Korea Bioelectronic Medicine Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Type
      • 9.3.4.2.2. By Product
      • 9.3.4.2.3. By Application
      • 9.3.4.2.4. By End User
  • 9.3.5. Australia Bioelectronic Medicine Market Outlook
    • 9.3.5.1. Market Size & Forecast
      • 9.3.5.1.1. By Value
    • 9.3.5.2. Market Share & Forecast
      • 9.3.5.2.1. By Type
      • 9.3.5.2.2. By Product
      • 9.3.5.2.3. By Application
      • 9.3.5.2.4. By End User

10. South America Bioelectronic Medicine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (Implantable v/s Non-invasive)
  • 10.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
  • 10.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
  • 10.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Bioelectronic Medicine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Argentina Bioelectronic Medicine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Colombia Bioelectronic Medicine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Middle East and Africa Bioelectronic Medicine Market Outlook

• 11.1. Market Size & Forecast
  • 11.1.1. By Value
• 11.2. Market Share & Forecast
  • 11.2.1. By Type (Implantable v/s Non-invasive)
  • 11.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
  • 11.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
  • 11.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
  • 11.2.5. By Country
• 11.3. MEA: Country Analysis
  • 11.3.1. South Africa Bioelectronic Medicine Market Outlook
    • 11.3.1.1. Market Size & Forecast
      • 11.3.1.1.1. By Value
    • 11.3.1.2. Market Share & Forecast
      • 11.3.1.2.1. By Type
      • 11.3.1.2.2. By Product
      • 11.3.1.2.3. By Application
      • 11.3.1.2.4. By End User
  • 11.3.2. Saudi Arabia Bioelectronic Medicine Market Outlook
    • 11.3.2.1. Market Size & Forecast
      • 11.3.2.1.1. By Value
    • 11.3.2.2. Market Share & Forecast
      • 11.3.2.2.1. By Type
      • 11.3.2.2.2. By Product
      • 11.3.2.2.3. By Application
      • 11.3.2.2.4. By End User
  • 11.3.3. UAE Bioelectronic Medicine Market Outlook
    • 11.3.3.1. Market Size & Forecast
      • 11.3.3.1.1. By Value
    • 11.3.3.2. Market Share & Forecast
      • 11.3.3.2.1. By Type
      • 11.3.3.2.2. By Product
      • 11.3.3.2.3. By Application
      • 11.3.3.2.4. By End User

12. Market Dynamics

• 12.1. Drivers
• 12.2. Challenges

13. Market Trends & Developments

• 13.1. Recent Developments
• 13.2. Mergers & Acquisitions
• 13.3. Product Launches

14. Global Bioelectronic Medicine Market: SWOT Analysis

15. Porter's Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Products

16. Competitive Landscape

• 16.1. Medtronic plc
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (As Reported)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. Abbott Laboratories
• 16.3. Boston Scientific Corporation
• 16.4. Cochlear Ltd.
• 16.5. LivaNova PLC
• 16.6. Soterix Medical Inc.
• 16.7. Bioinduction Ltd.
• 16.8. GiMer Medical
• 16.9. CEFALY
• 16.10. BioControl Medical

17. Strategic Recommendations

18. About Us & Disclaimer